DelMar Pharmaceuticals, Inc.
Suite 720-999 West Broadway
Vancouver, British Columbia
Canada V5Z 1K5
May 14, 2015
EDGAR
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | DelMar Pharmaceuticals, Inc. | |
| Registration Statement on Form S-1 | ||
| File No. 333-203357 | ||
Ladies and Gentlemen:
DelMar Pharmaceuticals, Inc. hereby requests withdrawal of its request for the acceleration of effectiveness of the above-referenced registration statement as set forth in its letter dated May 12, 2015.
| DelMar Pharmaceuticals, Inc. | ||
| By: | /s/ Jeffrey Bacha | |
| Name: Jeffrey Bacha Title: Chief Executive Officer | ||